231 related articles for article (PubMed ID: 21605697)
1. To measure is to know: an approach to CADD performance metrics.
Loughney D; Claus BL; Johnson SR
Drug Discov Today; 2011 Jul; 16(13-14):548-54. PubMed ID: 21605697
[TBL] [Abstract][Full Text] [Related]
2. Portfolio management in early stage drug discovery - a traveler's guide through uncharted territory.
Betz UA
Drug Discov Today; 2011 Jul; 16(13-14):609-18. PubMed ID: 21600301
[TBL] [Abstract][Full Text] [Related]
3. Drug discovery: are productivity metrics inhibiting motivation and creativity?
Ullman F; Boutellier R
Drug Discov Today; 2008 Nov; 13(21-22):997-1001. PubMed ID: 18652910
[TBL] [Abstract][Full Text] [Related]
4. What is the most important approach in current drug discovery: doing the right things or doing things right?
Elebring T; Gill A; Plowright AT
Drug Discov Today; 2012 Nov; 17(21-22):1166-9. PubMed ID: 22569181
[TBL] [Abstract][Full Text] [Related]
5. Computational chemistry at Janssen.
van Vlijmen H; Desjarlais RL; Mirzadegan T
J Comput Aided Mol Des; 2017 Mar; 31(3):267-273. PubMed ID: 27995515
[TBL] [Abstract][Full Text] [Related]
6. Value networks identify innovation in 21st century pharmaceutical research.
Edwards PJ
Drug Discov Today; 2009 Jan; 14(1-2):68-77. PubMed ID: 18973823
[TBL] [Abstract][Full Text] [Related]
7. Ask the experts: the challenges and benefits of flow chemistry to optimize drug development.
Anderson N; Gernaey KV; Jamison TF; Kircher M; Wiles C; Leadbeater NE; Sandford G; Richardson P
Future Med Chem; 2012 Sep; 4(14):1779-89. PubMed ID: 23043475
[TBL] [Abstract][Full Text] [Related]
8. Tools, techniques, organisation and culture of the CADD group at Sygnature Discovery.
St-Gallay SA; Sambrook-Smith CP
J Comput Aided Mol Des; 2017 Mar; 31(3):305-308. PubMed ID: 27798721
[TBL] [Abstract][Full Text] [Related]
9. ROCK: the Roche medicinal chemistry knowledge application - design, use and impact.
Mayweg A; Hofer U; Schnider P; Agnetti F; Galley G; Mattei P; Lucas M; Boehm HJ
Drug Discov Today; 2011 Aug; 16(15-16):691-6. PubMed ID: 21439402
[TBL] [Abstract][Full Text] [Related]
10. An unbalanced portfolio.
Federsel HJ
Drug News Perspect; 2009 Jun; 22(5):287-92. PubMed ID: 19609466
[TBL] [Abstract][Full Text] [Related]
11. The evolution of drug design at Merck Research Laboratories.
Brown FK; Sherer EC; Johnson SA; Holloway MK; Sherborne BS
J Comput Aided Mol Des; 2017 Mar; 31(3):255-266. PubMed ID: 27878643
[TBL] [Abstract][Full Text] [Related]
12. Improving lead generation success through integrated methods: transcending 'drug discovery by numbers'.
Campbell JB
IDrugs; 2010 Dec; 13(12):874-9. PubMed ID: 21154146
[TBL] [Abstract][Full Text] [Related]
13. How should we support pharmaceutical innovation?
Grootendorst P
Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
[TBL] [Abstract][Full Text] [Related]
14. Research & market strategy: how choice of drug discovery approach can affect market position.
Sams-Dodd F
Drug Discov Today; 2007 Apr; 12(7-8):314-8. PubMed ID: 17395091
[TBL] [Abstract][Full Text] [Related]
15. A case study of lean drug discovery: from project driven research to innovation studios and process factories.
Ullman F; Boutellier R
Drug Discov Today; 2008 Jun; 13(11-12):543-50. PubMed ID: 18549982
[TBL] [Abstract][Full Text] [Related]
16. Combining label-free cell phenotypic profiling with computational approaches for novel drug discovery.
Fang Y
Expert Opin Drug Discov; 2015 Apr; 10(4):331-43. PubMed ID: 25727255
[TBL] [Abstract][Full Text] [Related]
17. Does R&D pay?
Cavalla D; Minhas R
Drug Discov Today; 2010 Mar; 15(5-6):230-4. PubMed ID: 19931643
[TBL] [Abstract][Full Text] [Related]
18. Molecular topology as a novel approach for drug discovery.
Gálvez J; Gálvez-Llompart M; García-Domenech R
Expert Opin Drug Discov; 2012 Feb; 7(2):133-53. PubMed ID: 22468915
[TBL] [Abstract][Full Text] [Related]
19. Computer-aided drug discovery research at a global contract research organization.
Kitchen DB
J Comput Aided Mol Des; 2017 Mar; 31(3):309-318. PubMed ID: 27804014
[TBL] [Abstract][Full Text] [Related]
20. In silico lead identification and optimization for drug discovery.
Zhang S
Curr Pharm Des; 2012; 18(9):1171-2. PubMed ID: 22316149
[No Abstract] [Full Text] [Related]
[Next] [New Search]
